Harnessing baicalein to mitigate antibiotic resistance: resensitizing norfloxacin against urinary multidrug-resistant Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa
DOI:
https://doi.org/10.18203/2320-6012.ijrms20260811Keywords:
UTI, E. coli, K. pneumoniae, P. aeruginosa, Norfloxacin, Baicalein, Antimicrobial resistanceAbstract
Background: According to the World Health Organization (WHO) Priority Pathogen List — 2024, multidrug-resistant pathogens will emerge and spread rapidly in the coming years. This has to be countered by the urgent development of novel antibiotics for their effective management. Restoring and enhancing the potency of existing antibiotics by combining with bioactive compounds is a novel strategy to be further studied. The purpose of our study is to determine the synergistic effect of one of the active ingredients from Chinese skullcap, baicalein with norfloxacin on multi-drug resistant uropathogens.
Methods: The present cross-sectional study was undertaken at School of Medical Education (SME), Kerala, India, during the period of November 2023 to November 2024. Based on the calculated FICI values, results were interpreted as Synergy (FICI≤0.5), Additive (0.5<FICI≤1), Indifferent (1<FICI≤4), Antagonistic (FICI>4). The data were analysed using Microsoft Excel software (Windows 2010). Chi-square test was performed using IBM statistical package for the social sciences (SPSS) Statistics 24 to evaluate significant differences (p value <0.05) among the parameters examined in this study.
Results: A total of 150 drug-resistant strains of E. coli, K. pneumoniae and P. aeruginosa were isolated from urinary tract infections (UTIs). Resistance to norfloxacin was observed in 64% of E. coli, 68% of K. pneumoniae, and 74% of P. aeruginosa isolates. Notably, baicalein resensitized 56.3% of E. coli, 70.6% of K. pneumoniae, and 75.7% of P. aeruginosa strains to norfloxacin, as determined by the checkerboard assay and these findings were statistically significant.
Conclusions: This study emphasizes the need for ongoing surveillance of antimicrobial resistance in common urinary pathogens and also suggests that natural compounds like baicalein may resensitize existing antibiotics like norfloxacin against resistant strains, warranting further research into the underlying mechanisms and potential clinical applications.
Metrics
References
Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, et al. Community-associated extended-spectrum β-lactamase–producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641-8. DOI: https://doi.org/10.1093/cid/cis942
Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs DE, Bianco N. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother. 1996;40(9):2021-8. DOI: https://doi.org/10.1128/AAC.40.9.2021
Fujita M, Shiota S, Kuroda T, Hatano T, Yoshida T, Mizushima T, et al. Remarkable synergies between baicalein and tetracycline, and baicalein and β‐lactams against methicillin‐resistant Staphylococcus aureus. Microbiol Immunol. 2005;49(4):391-6. DOI: https://doi.org/10.1111/j.1348-0421.2005.tb03732.x
Chang PC, Li HY, Tang HJ, Liu JW, Wang JJ, Chuang YC. In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus. J Microbiol Immunol Infect. 2007;40(1):56-61.
Chan BC, Ip M, Lau CB, Lui SL, Jolivalt C, Ganem-Elbaz C, et al. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J Ethnopharmacol. 2011;137(1):767-73. DOI: https://doi.org/10.1016/j.jep.2011.06.039
Leigh DA, Emmanuel FX. The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin. J Antimicrob Chemother. 1984;13(B):85-8. DOI: https://doi.org/10.1093/jac/13.suppl_B.85
CLSI: Performance Standards for Antimicrobial Disk Susceptibility Tests, 13th edition. CLSI standard M02, Wayne, PA: Clinical and Laboratory Standards Institute. 2018.
CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th edition. CLSI supplement M100. Clinical and Laboratory Standards Institute. 2024.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. DOI: https://doi.org/10.1111/j.1469-0691.2011.03570.x
CLSI M07: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th edition. Wayne, PA: Clinical and Laboratory Standards Institute. 2018.
Sivadas A, Sajeev A, Kumar HKS, Krishnan S. Detection of colistin susceptibility in extended spectrum β lactamases positive Klebsiella pneumoniae and Escherichia coli clinical isolates by broth disc elution method. Int J Res Med Sci. 2024;12(4):1203. DOI: https://doi.org/10.18203/2320-6012.ijrms20240844
Dash M, Padhi S, Mohanty I, Panda P, Parida B. Antimicrobial resistance in pathogens causing urinary tract infections in a rural community of Odisha, India. J Family Community Med. 2013;20(1):20-6. DOI: https://doi.org/10.4103/2230-8229.108180
Veeraraghavan B, Jesudason MR, Prakasah JA, Anandan S, Sahni RD, Pragasam AK, et al. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014–2016: Study for monitoring antimicrobial resistance trend report. Indian J Med Microbiol. 2018;36(1):32-6. DOI: https://doi.org/10.4103/ijmm.IJMM_17_415
Jalil MB, Al Atbee MY. The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. J Clin Laboratory Analysis. 2022;36(9):e24619. DOI: https://doi.org/10.1002/jcla.24619
Regha IR. Prevalence and antibiotic susceptibility patterns of pseudomonas aeruginosa in urinary tractSinfections in a Tertiary care hospital, Central Kerala: A retrospective study over 4 rears. Trop J Pathol Microbiol. 2018;4:52-8. DOI: https://doi.org/10.17511/jopm.2018.i01.09
Chander A, Shrestha CD. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. BMC Res Notes. 2013;6:1-6. DOI: https://doi.org/10.1186/1756-0500-6-487
Sah BK, Dahal P, Mallik SK, Paul AD, Mainali U, Shah C, Dahal P. Uropathogens and their antimicrobial-resistant pattern among suspected urinary tract infections patients in eastern Nepal: A hospital inpatients-based study. SAGE Open Med. 2023;11:20503121231220821. DOI: https://doi.org/10.1177/20503121231220821
Shrestha A, Manandhar S, Pokharel P, Panthi P, Chaudhary DK. Prevalence of extended spectrum beta-lactamase (ESBL) producing multidrug resistance gram-negative isolates causing urinary tract infection. EC Microbiol. 2016;4(5):749-55.
Usman NI, Abdulwahab NM, Sulaiman MJ. Multidrug Resistance (MDR), Extensive Drug Resistance (XDR) and Pan Drug Resistance (PDR) Klebsiella Pneumoniae from Clinical Samples. SLU J Sci Technol. 2022;3:42-50. DOI: https://doi.org/10.5455/sf.98561
Senthamarai S, Sivasankari S, Anitha C, Somasunder V, Kumudhavathi MS, Amshavathani SK, et al. Resistance pattern of Pseudomonas aeruginosa in a tertiary care hospital of Kanchipuram, Tamilnadu, India. J Clin Diagnost Res. 2014;8(5):DC30. DOI: https://doi.org/10.7860/JCDR/2014/7953.4388
Singh P, Lal V, Malik S. Emergence of Extremely Drug Resistant and Pan Drug Resistant Acinetobacter baumanii and Pseudomonas aeruginosa Isolated from Diverse Samples in Delhi. Am J Infect Dis. 2020;8(4):132-8. DOI: https://doi.org/10.12691/ajidm-8-4-3
Wajid M, Mallamgunta S, Pedapati VP, Naaz S. A study on evaluation of Escherichia coli isolates in urinary tract infection and its antibiogram in view of Emerging drug resistance at a tertiary care hospital. Trop J Pathol Microbiol. 2022;7(06):272-9.
Raei F, Eftekhar F, Feizabadi MM. Prevalence of quinolone resistance among extended-spectrum β-lactamase producing uropathogenic Klebsiella pneumoniae. Jundishapur J Microbiol. 2014;7(6). DOI: https://doi.org/10.5812/jjm.10887
Metri BC, Jyothi P. Antimicrobial resistance of Pseudomonas aeruginosa strains from patients with urinary tract infections in SBMPMC hospital Bijapur, India. Int J Pharmacy Pharm Sci. 2014;1:479-81.
Wang Y, Su J, Zhou Z, Yang J, Liu W, Zhang Y, et al. Baicalein resensitizes multidrug-resistant gram-negative pathogens to doxycycline. Microbiol Spectrum. 2023;11(3):e04702-22. DOI: https://doi.org/10.1128/spectrum.04702-22
Güran M, Çakıral K, Teralı K, Kandemir T, Şanlıtürk G, Öcal MM, et al. Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro. Pathogens Dis. 2023;81:ftad007. DOI: https://doi.org/10.1093/femspd/ftad007
Cai W, Fu Y, Zhang W, Chen X, Zhao J, Song W, et al. Synergistic effects of baicalein with cefotaxime against Klebsiella pneumoniae through inhibiting CTX-M-1 gene expression. BMC Microbiol. 2016;16:1-9. DOI: https://doi.org/10.1186/s12866-016-0797-1
Downloads
Published
How to Cite
Issue
Section
